ValuEngine upgraded shares of Nuvectra (NASDAQ:NVTR) from a sell rating to a hold rating in a research report sent to investors on Monday.
Other research analysts have also recently issued research reports about the company. SunTrust Banks initiated coverage on Nuvectra in a research report on Thursday, March 29th. They set a buy rating on the stock. JMP Securities initiated coverage on Nuvectra in a research report on Wednesday, February 14th. They set an outperform rating on the stock. Finally, Piper Jaffray raised Nuvectra from a neutral rating to an overweight rating in a research report on Friday, March 16th. Two analysts have rated the stock with a hold rating and four have issued a buy rating to the company. The company currently has an average rating of Buy and a consensus price target of $12.00.
Shares of NASDAQ:NVTR opened at $13.34 on Monday. The company has a market cap of $181.44, a P/E ratio of -3.19 and a beta of -2.28. The company has a debt-to-equity ratio of 0.54, a quick ratio of 2.50 and a current ratio of 2.81. Nuvectra has a 12-month low of $6.31 and a 12-month high of $15.00.
A number of hedge funds have recently bought and sold shares of the business. Dimensional Fund Advisors LP boosted its position in Nuvectra by 4.0% in the third quarter. Dimensional Fund Advisors LP now owns 730,117 shares of the company’s stock worth $9,681,000 after purchasing an additional 28,268 shares during the last quarter. AWH Capital L.P. purchased a new position in Nuvectra in the fourth quarter worth $3,597,000. Rockefeller Financial Services Inc. boosted its position in Nuvectra by 297.9% in the fourth quarter. Rockefeller Financial Services Inc. now owns 428,644 shares of the company’s stock worth $3,326,000 after purchasing an additional 320,914 shares during the last quarter. Lomas Capital Management LLC boosted its position in Nuvectra by 7.4% in the fourth quarter. Lomas Capital Management LLC now owns 395,406 shares of the company’s stock worth $3,068,000 after purchasing an additional 27,206 shares during the last quarter. Finally, Wells Fargo & Company MN boosted its position in Nuvectra by 14.6% in the fourth quarter. Wells Fargo & Company MN now owns 127,665 shares of the company’s stock worth $991,000 after purchasing an additional 16,244 shares during the last quarter. 46.93% of the stock is currently owned by institutional investors and hedge funds.
Nuvectra Company Profile
Nuvectra Corporation is a neurostimulation company that focuses on helping physicians to improve the lives of people with chronic neurological conditions. The Company’s Algovita Spinal Cord Stimulation (SCS) System (Algovita) is the Company’s commercial offering and is Conformite Europeene (CE) marked and the United States Food and Drug Administration (FDA) approved for the treatment of chronic pain of the trunk and/or limbs.
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Nuvectra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuvectra and related companies with MarketBeat.com's FREE daily email newsletter.